United Therapeutics (UTHR) News Today $280.62 -3.69 (-1.30%) As of 11:25 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Invesco Ltd. Purchases 24,466 Shares of United Therapeutics Co. (NASDAQ:UTHR)Invesco Ltd. grew its position in United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 8.3% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 318,451 shares of the biotechnology company's stock after purchasing an additional 24,466 sharApril 15 at 4:07 AM | marketbeat.comBank of Montreal Can Has $6.76 Million Stake in United Therapeutics Co. (NASDAQ:UTHR)Bank of Montreal Can reduced its position in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 49.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 19,168 shares of the biotechnology company's stoApril 15 at 4:07 AM | marketbeat.comCerity Partners LLC Buys 2,702 Shares of United Therapeutics Co. (NASDAQ:UTHR)Cerity Partners LLC grew its position in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 30.4% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 11,588 shares of the biotechnology company's stock after purchasing an additional 2April 15 at 3:59 AM | marketbeat.comCapital Fund Management S.A. Has $14.20 Million Holdings in United Therapeutics Co. (NASDAQ:UTHR)Capital Fund Management S.A. increased its stake in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 35.7% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 40,233 shares of the biotechnology company's stock after acquiring anApril 14 at 5:50 AM | marketbeat.comF M Investments LLC Purchases Shares of 2,404 United Therapeutics Co. (NASDAQ:UTHR)F M Investments LLC acquired a new position in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 2,404 shares of the biotechnology company's stock, valued at approximately $April 14 at 5:41 AM | marketbeat.comLegal & General Group Plc Decreases Stake in United Therapeutics Co. (NASDAQ:UTHR)Legal & General Group Plc reduced its position in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 28.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 173,759 shares of the biotechnology companyApril 14 at 4:58 AM | marketbeat.comAviva PLC Reduces Holdings in United Therapeutics Co. (NASDAQ:UTHR)Aviva PLC lessened its position in United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 80.0% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,658 shares of the biotechnology company's stock after selling 6,623 shares duringApril 13 at 4:57 AM | marketbeat.comParalel Advisors LLC Acquires 992 Shares of United Therapeutics Co. (NASDAQ:UTHR)Paralel Advisors LLC lifted its stake in United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 10.0% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,929 shares of the biotechnology company's stock afterApril 12 at 10:02 AM | marketbeat.comUnited Therapeutics Co. (NASDAQ:UTHR) Shares Purchased by Andrew Hill Investment Advisors Inc.Andrew Hill Investment Advisors Inc. grew its stake in United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 79.6% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 13,634 shares of the biotechnology company's stock after acquiring an additional 6,044April 12 at 9:22 AM | marketbeat.comLSV Asset Management Has $320.63 Million Stock Position in United Therapeutics Co. (NASDAQ:UTHR)LSV Asset Management lessened its stake in United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 6.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 908,724 shares of the biotechnology companyApril 12 at 8:07 AM | marketbeat.comUnited Therapeutics Co. (NASDAQ:UTHR) Shares Sold by Martingale Asset Management L PMartingale Asset Management L P trimmed its holdings in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 6.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 34,65April 12 at 6:46 AM | marketbeat.comFmr LLC Has $519.17 Million Stock Position in United Therapeutics Co. (NASDAQ:UTHR)Fmr LLC grew its stake in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 36.5% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,471,405 shares of the biotechnology company's stock after purchasing an adApril 12 at 5:41 AM | marketbeat.comBrokerages Set United Therapeutics Co. (NASDAQ:UTHR) Target Price at $388.25April 12 at 2:21 AM | americanbankingnews.com2 of Wall Street’s Favorite Stocks to Target This Week and 1 to QuestionApril 11, 2025 | finance.yahoo.comExodusPoint Capital Management LP Makes New $1.90 Million Investment in United Therapeutics Co. (NASDAQ:UTHR)ExodusPoint Capital Management LP bought a new stake in United Therapeutics Co. (NASDAQ:UTHR - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 5,383 shares of the biotechnology company's stock, valued atApril 11, 2025 | marketbeat.comUnited Therapeutics Co. (NASDAQ:UTHR) Director Sells $1,138,200.00 in StockApril 11, 2025 | americanbankingnews.comInsider Selling: United Therapeutics Co. (NASDAQ:UTHR) Director Sells 4,000 Shares of StockUnited Therapeutics Co. (NASDAQ:UTHR - Get Free Report) Director Raymond Dwek sold 4,000 shares of the company's stock in a transaction on Monday, April 7th. The stock was sold at an average price of $284.55, for a total transaction of $1,138,200.00. Following the sale, the director now directly owns 1,750 shares of the company's stock, valued at approximately $497,962.50. This trade represents a 69.57 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.April 10, 2025 | marketbeat.comUnited Therapeutics Co. (NASDAQ:UTHR) Shares Sold by Renaissance Technologies LLCRenaissance Technologies LLC decreased its stake in United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 3.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,089,392 shares of the biotechnology company's stock afteApril 10, 2025 | marketbeat.comRussell Investments Group Ltd. Purchases 22,895 Shares of United Therapeutics Co. (NASDAQ:UTHR)Russell Investments Group Ltd. boosted its holdings in United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 35.1% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 88,077 shares of the biotechnology compaApril 10, 2025 | marketbeat.comGrantham Mayo Van Otterloo & Co. LLC Increases Holdings in United Therapeutics Co. (NASDAQ:UTHR)Grantham Mayo Van Otterloo & Co. LLC boosted its position in United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 101.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 8,227 shares of the biotechnologApril 10, 2025 | marketbeat.comResona Asset Management Co. Ltd. Makes New Investment in United Therapeutics Co. (NASDAQ:UTHR)Resona Asset Management Co. Ltd. purchased a new stake in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 19,532 shares of the biotechnology company's stock,April 10, 2025 | marketbeat.comLPL Financial LLC Has $5.02 Million Position in United Therapeutics Co. (NASDAQ:UTHR)LPL Financial LLC boosted its position in United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 122.8% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 14,239 shares of the biotechnology company's stock after purchasing an adApril 10, 2025 | marketbeat.comUnited Therapeutics Co. (NASDAQ:UTHR) Given Average Rating of "Moderate Buy" by BrokeragesUnited Therapeutics Co. (NASDAQ:UTHR - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the twelve research firms that are presently covering the company, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, two have issued a hold reApril 10, 2025 | marketbeat.comPaul A. Mahon Sells 11,000 Shares of United Therapeutics Co. (NASDAQ:UTHR) StockUnited Therapeutics Co. (NASDAQ:UTHR - Get Free Report) EVP Paul A. Mahon sold 11,000 shares of the stock in a transaction that occurred on Thursday, April 3rd. The stock was sold at an average price of $306.18, for a total transaction of $3,367,980.00. Following the completion of the sale, the executive vice president now owns 36,781 shares in the company, valued at $11,261,606.58. This represents a 23.02 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.April 9, 2025 | marketbeat.comUnited Therapeutics Co. (NASDAQ:UTHR) Director Raymond Dwek Sells 4,000 SharesApril 9, 2025 | insidertrades.comAtika Capital Management LLC Boosts Stake in United Therapeutics Co. (NASDAQ:UTHR)Atika Capital Management LLC raised its stake in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 12.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 31,000 shares of the biotechnology compaApril 8, 2025 | marketbeat.comUnited Therapeutics Co. (NASDAQ:UTHR) EVP Paul A. Mahon Sells 11,000 SharesApril 8, 2025 | insidertrades.comLiquidia: United Therapeutics Has The Last LaughApril 7, 2025 | seekingalpha.comIntegrated Quantitative Investments LLC Buys Shares of 1,110 United Therapeutics Co. (NASDAQ:UTHR)Integrated Quantitative Investments LLC purchased a new stake in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The fund purchased 1,110 shares of the biotechnology company's stock, valued at approximatelyApril 7, 2025 | marketbeat.comGeode Capital Management LLC Buys 44,277 Shares of United Therapeutics Co. (NASDAQ:UTHR)Geode Capital Management LLC lifted its position in United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 4.0% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,138,292 shares of the biotechnology company's stockApril 7, 2025 | marketbeat.comBryce Point Capital LLC Purchases Shares of 3,522 United Therapeutics Co. (NASDAQ:UTHR)Bryce Point Capital LLC acquired a new stake in United Therapeutics Co. (NASDAQ:UTHR - Free Report) during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 3,522 shares of the biotechnology company's stock, valued at approximatelyApril 5, 2025 | marketbeat.comHeadlands Technologies LLC Sells 1,464 Shares of United Therapeutics Co. (NASDAQ:UTHR)Headlands Technologies LLC reduced its holdings in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 35.6% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 2,647 shares of the biotechnology company'sApril 4, 2025 | marketbeat.comFranklin Resources Inc. Increases Stake in United Therapeutics Co. (NASDAQ:UTHR)Franklin Resources Inc. grew its stake in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 31.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 329,379 shares of the biotechnology company's stock after purchasing an adApril 4, 2025 | marketbeat.comAllstate Corp Acquires Shares of 1,176 United Therapeutics Co. (NASDAQ:UTHR)Allstate Corp bought a new position in United Therapeutics Co. (NASDAQ:UTHR - Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 1,176 shares of the biotechnology company's stock, valued at approximately $415,000. OthApril 4, 2025 | marketbeat.comUnited Therapeutics Co. (NASDAQ:UTHR) Shares Sold by American Century Companies Inc.American Century Companies Inc. lowered its position in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 23.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 38,152 shaApril 3, 2025 | marketbeat.comUnited Therapeutics Named to ‘100 Best Companies to Work For’ in 2025 by Fortune Media and Great Place to WorkApril 2, 2025 | finance.yahoo.comUnited Therapeutics Corp (UTHR) Recognized as a Top Employer by FortuneApril 2, 2025 | gurufocus.comIs United Therapeutics Corporation (UTHR) The Most Profitable Biotech Stock To Buy Right Now?April 2, 2025 | insidermonkey.comUnited Therapeutics Co. (NASDAQ:UTHR) Shares Acquired by Alliancebernstein L.P.Alliancebernstein L.P. increased its position in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 28.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 709,043 shares of theApril 2, 2025 | marketbeat.comAxiom Investors LLC DE Increases Position in United Therapeutics Co. (NASDAQ:UTHR)Axiom Investors LLC DE raised its holdings in United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 9.3% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 10,040 shares of the biotechnology company's stock after acApril 2, 2025 | marketbeat.comWellington Management Group LLP Reduces Holdings in United Therapeutics Co. (NASDAQ:UTHR)Wellington Management Group LLP reduced its position in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 22.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,463,April 2, 2025 | marketbeat.comUnited Therapeutics Co. (NASDAQ:UTHR) Shares Sold by Brandywine Global Investment Management LLCBrandywine Global Investment Management LLC lessened its holdings in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 6.7% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 27,123 shares of the biotechnology company's stock after selling 1,960 sApril 2, 2025 | marketbeat.comCalifornia Public Employees Retirement System Lowers Holdings in United Therapeutics Co. (NASDAQ:UTHR)California Public Employees Retirement System reduced its stake in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 1.2% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 209,204 shares of the biotechnology company's stock after selling 2,618 sApril 2, 2025 | marketbeat.comSchroder Investment Management Group Lowers Stake in United Therapeutics Co. (NASDAQ:UTHR)Schroder Investment Management Group trimmed its holdings in United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 1.2% in the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 163,782 shares of the biotechnology company's stock after selling 2,020 shares duringApril 2, 2025 | marketbeat.comNomura Asset Management Co. Ltd. Has $8.69 Million Stock Position in United Therapeutics Co. (NASDAQ:UTHR)Nomura Asset Management Co. Ltd. cut its holdings in United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 4.0% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 24,621 shares of the biotechnology company's stock afterApril 2, 2025 | marketbeat.comNorges Bank Takes Position in United Therapeutics Co. (NASDAQ:UTHR)Norges Bank purchased a new position in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 430,122 shares of the biotechnology company's stock, valued atApril 2, 2025 | marketbeat.comUniSuper Management Pty Ltd Sells 13,826 Shares of United Therapeutics Co. (NASDAQ:UTHR)UniSuper Management Pty Ltd lessened its position in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 94.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 800 shares of the biotechnologApril 2, 2025 | marketbeat.comMitsubishi UFJ Asset Management Co. Ltd. Purchases 3,312 Shares of United Therapeutics Co. (NASDAQ:UTHR)Mitsubishi UFJ Asset Management Co. Ltd. increased its position in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 11.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 32,246 shares of the bioteApril 2, 2025 | marketbeat.comNotable Monday Option Activity: UTHR, TEAM, UNHApril 2, 2025 | nasdaq.comArrowstreet Capital Limited Partnership Sells 99,154 Shares of United Therapeutics Co. (NASDAQ:UTHR)Arrowstreet Capital Limited Partnership cut its holdings in United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 15.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 542,445 shares of the biotechnology company's stoApril 1, 2025 | marketbeat.com Remove Ads Get United Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for UTHR and its competitors with MarketBeat's FREE daily newsletter. Email Address UTHR Media Mentions By Week UTHR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. UTHR News Sentiment▼1.480.80▲Average Medical News Sentiment UTHR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. UTHR Articles This Week▼2712▲UTHR Articles Average Week Remove Ads Get United Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for UTHR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ALNY News BIIB News INCY News BMRN News EXEL News NBIX News EXAS News HALO News RGEN News MDGL News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:UTHR) was last updated on 4/15/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon’s Silver Play? Trump Clears the PathNothing is confirmed—yet. But Musk has disrupted every industry he's touched, and Trump's policies make the ti...Priority Gold | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding United Therapeutics Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share United Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
